Eddy Jean Edgard Freyne

This inventor holds 46 USPTO granted patents and 3 published patent applications, plus 10 CIPO patents and 14 EPO patents, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Astex Therapeutics Limited, Jannsen-Cilag S.a.. Active years: 2001-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eddy Jean Edgard Freyne. Retrieved from https://idiyas.com/inventor/eddy-jean-edgard-freyne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 (Patent Applications = 3)

% Patents Active = 71.7

CIPO Patents = 10

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 6.1

ph-index = 10

Forward Citations = 330(Granted Patents)

Location History:

2340 Beerse, BE (2007)
Beerse, BE (2002 - 2015)
Rumst, BE (2001 - 2019)

Company Filing History:

34 out of 2,101

Janssen Pharmaceutica Nv

patents

7 out of 126

Astex Therapeutics Limited

5. 3 out of 834,570

Other

patents

Years Active: 2001-2019

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Quinazoline Derivatives

IL-5 Inhibitors

Antiproliferative Agents

Pyrazolyl Compounds

Macrocyclic Derivatives

Triazolopyrimidine

Heteroaryl Amines

Bicyclic Heterocycles

Pyrimidine Derivatives

3-Cyano-Quinoline

FGFR Inhibitors

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10519137 - Pyrazolyl quinoxaline kinase inhibitors (2019-12-31),

2. 10208062 - Macrocyclic quinazole derivatives and their use as MTKI (2019-02-19),

3. 9850228 - Pyrazolyl quinoxaline kinase inhibitors (2017-12-26),

4. 9688691 - Macrocyclic quinazole derivatives and their use as MTKI (2017-06-27),

5. 9464071 - Pyrazolyl quinoxaline kinase inhibitors (2016-10-11),

6. 9365517 - 3-cyano-quinoline derivatives with antiproliferative activity (2016-06-14),

7. 9273013 - Quinazoline derivatives (2016-03-01),

8. 9040511 - 3-cyano-quinoline derivatives with antiproliferative activity (2015-05-26),

9. 8895601 - Pyrazolyl quinoxaline kinase inhibitors (2014-11-25),

10. 8796244 - Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases (2014-08-05),

11. 8778966 - Quinolinone derivatives as PARP and tank inhibitors (2014-07-15),

12. 8778920 - 3-cyano-quinoline derivatives with antiproliferative activity (2014-07-15),

13. 8772272 - Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents (2014-07-08),

14. 8722687 - Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy (2014-05-13),

15. 8492377 - MTKI quinazoline derivatives (2013-07-23),

Title: Eddy Jean Edgard Freyne: Pioneering Technological Innovations

Introduction: Eddy Jean Edgard Freyne, a brilliant inventor hailing from Rumst, Belgium, has left an indelible mark in the realm of technology. With a passion for innovation and a remarkable knack for inventing, he stands as a beacon for aspiring inventors worldwide.

Latest Patents: Among his impressive portfolio of 46 patents, Eddy Jean Edgard Freyne's recent inventions include groundbreaking discoveries such as Pyrazolyl quinoxaline kinase inhibitors, revolutionizing the treatment of diseases like cancer. Additionally, his Macrocyclic quinazole derivatives have paved the way for advancements in medicinal chemistry.

Career Highlights: Eddy Jean Edgard Freyne has lent his expertise to renowned companies such as Janssen Pharmaceutica N.V. and Astex Therapeutics Limited, where his inventive spirit flourished. Through his innovative contributions, he has significantly impacted the technological landscape, shaping the future of healthcare and beyond.

Collaborations: Throughout his illustrious career, Eddy Jean Edgard Freyne has collaborated with esteemed coworkers like Werner Constant Johan Embrechts and Timothy Pietro Suren Perera. Together, they have synergized their talents to bring forth groundbreaking inventions and propel technological advancements.

Conclusion: Eddy Jean Edgard Freyne's relentless pursuit of innovation and his unparalleled talent for inventing have solidified his position as a trailblazer in the world of technology. His remarkable contributions continue to inspire and drive the next generation of inventors towards shaping a brighter technological future.

Profile summary based on public USPTO records.